Arkolith/Insider Trading/AVTE/Form 4

Gillies Hunter

CHIEF MEDICAL OFFICERAerovate Therapeutics, Inc. (AVTE) · full profile →Form 4 · filed Apr 19, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$90K
Net Open-Market Flow
-$90K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 17, 2024Sell(S)311$23.33$7K3K
Apr 17, 2024Option exercise(M)4K$1.74$7K7K
Apr 17, 2024Sell(S)4K$22.30$82K4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 17, 2024Option exercise(M)3K—$0539
Apr 17, 2024Option exercise(M)503—$03K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-011251) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML